These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 234294

  • 1. Sequential evaluation of general immune competence in cancer patients: correlation with clinical course.
    Eilber FR, Nizze JA, Morton DL.
    Cancer; 1975 Mar; 35(3):660-5. PubMed ID: 234294
    [Abstract] [Full Text] [Related]

  • 2. Effect of BCG (Tice strain) on primary sensitization to 2,4-dinitrochlorobenzene and on established delayed hypersensitivity in human malignant melanoma.
    Mavligit GM, Gutterman JU, Hersh EM.
    J Natl Cancer Inst; 1976 Oct; 57(4):749-51. PubMed ID: 1003526
    [Abstract] [Full Text] [Related]

  • 3. DNCB sensitivity in cancer patients. A review based on sequential testing in 430 patients.
    Bolton PM.
    Clin Oncol; 1975 Mar; 1(1):59-69. PubMed ID: 1106933
    [No Abstract] [Full Text] [Related]

  • 4. Sequential evaluation of DNCB reactivity in patients with primary lung cancer. Correlation with prognosis.
    Inoue H, Ishihara T, Kobayashi K, Fukai S.
    J Thorac Cardiovasc Surg; 1978 Oct; 76(4):479-82. PubMed ID: 703354
    [Abstract] [Full Text] [Related]

  • 5. Immunological factors which influence response to immunotherapy in malignant melanoma.
    Morton D, Eilber FR, Malmgren RA, Wood WC.
    Surgery; 1970 Jul; 68(1):158-63; discussion 163-4. PubMed ID: 10483463
    [Abstract] [Full Text] [Related]

  • 6. Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: a randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene.
    Cohen MH, Jessup JM, Felix EL, Weese JL, Herberman RB.
    Cancer; 1978 Jun; 41(6):2456-63. PubMed ID: 657108
    [Abstract] [Full Text] [Related]

  • 7. Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer.
    Lee YT, Sparks FC, Eilber FR, Morton DL.
    Cancer; 1975 Mar; 35(3):748-55. PubMed ID: 1111942
    [Abstract] [Full Text] [Related]

  • 8. DNCB reactivity and prognosis in 419 patients with malignant melanoma.
    Camacho ES, Pinsky CM, Braun DW, Golbey RB, Fortner JG, Wanebo HJ, Oettgen HF.
    Cancer; 1981 May 15; 47(10):2446-50. PubMed ID: 7272900
    [Abstract] [Full Text] [Related]

  • 9. Active specific and active non-specific immunotherapy in patients with malignant melanoma.
    Kokoschka EM, Cerni C, Micksche M.
    Oncology; 1977 May 15; 34(5):229-33. PubMed ID: 917456
    [Abstract] [Full Text] [Related]

  • 10. [Immunotherapy of malignant melanoma (active specific and non-specific immune stimulation) (author's transl)].
    Kokoschka EM, Micksche M.
    Wien Klin Wochenschr; 1976 Nov 12; 88(21):690-6. PubMed ID: 1007279
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Monitoring immunotherapy with Bacillus Calmette-Guérin by antibody titer.
    Wile AG, Sparks FC, Morton DL.
    Cancer Res; 1977 Jul 12; 37(7 Pt 1):2251-6. PubMed ID: 324610
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Correlation of immune reactivity and clinical status in cancer.
    Chretien PB, Catalona WJ, Twomey PL, Sample WF.
    Ann Clin Lab Sci; 1974 Jul 12; 4(5):331-8. PubMed ID: 4851196
    [No Abstract] [Full Text] [Related]

  • 15. Immunotherapy of malignancy in humans. Current status.
    Holmes EC, Eilber FR, Morton DL.
    JAMA; 1975 Jun 09; 232(10):1052-5. PubMed ID: 236402
    [Abstract] [Full Text] [Related]

  • 16. [The DNCB skin test and its comparison with the radioimmunological determination of CEA in some types of neoplasms].
    Bianucci P, Pastorino G, De Rossi O.
    Minerva Med; 1979 May 26; 70(25):1795-801. PubMed ID: 572515
    [Abstract] [Full Text] [Related]

  • 17. A technique for intensifying BCG sensitivity.
    Parmett SR, Klein E.
    J Med; 1975 May 26; 6(3-4):213-6. PubMed ID: 1104733
    [Abstract] [Full Text] [Related]

  • 18. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
    Knopf B, Wätzig V, Knöll B.
    Arch Geschwulstforsch; 1978 May 26; 48(8):722-8. PubMed ID: 753194
    [Abstract] [Full Text] [Related]

  • 19. Immunological aspects of neoplasia: a rational basis for immunotherapy.
    Ann Intern Med; 1971 Apr 26; 74(4):587-604. PubMed ID: 4927902
    [No Abstract] [Full Text] [Related]

  • 20. Immunotherapy with viral oncolysates for sarcoma.
    Sinkovics JG.
    JAMA; 1977 Feb 28; 237(9):869. PubMed ID: 319278
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.